Imunon, Inc. Conversion of Stock, Shares Issued
Imunon, Inc. (IMNN) reported Conversion of Stock, Shares Issued of 15.83 thousand shares for the 12-month period ending 2013-12-31, per its 10-K filed 2016-03-30.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2016-03-30
- Imunon, Inc. conversion of stock, shares issued for the quarter ending 2013-03-31 was 81.10K shares.
- Imunon, Inc. conversion of stock, shares issued for fiscal 2013 was 15.83K shares, a 98.13% decline from fiscal 2012.
- Imunon, Inc. conversion of stock, shares issued for fiscal 2012 was 847.72K shares.
| Period end | Conversion of Stock, Shares Issued | Conversion of Stock, Shares Issued 0 month | Conversion of Stock, Shares Issued 1 month | Conversion of Stock, Shares Issued 3 month | Conversion of Stock, Shares Issued 12 month |
|---|---|---|---|---|---|
| 2013-12-31 | 15.83K shares 10-K · filed 2016-03-30 | ||||
| 2013-10-28 | 2.00 shares 10-Q · filed 2015-11-05 | 2.00 shares 10-Q · filed 2015-05-11 | |||
| 2013-03-31 | 81.10K shares 10-K · filed 2013-03-18 | ||||
| 2012-12-31 | 847.72K shares 10-K · filed 2015-03-12 | ||||
| 2011-08-08 | 462.96K shares 10-K · filed 2014-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |